Mats focuses primarily on the healthcare & life sciences sector in Europe. He is a German national and speaks German and English. His investment and board experience includes Lingoda and Viroclinics Biosciences.
Prior to Summit, Mats worked in the Consumer Retail, Healthcare and Real Estate M&A Group at Goldman Sachs. Mats holds a BS, with first class honors, in accounting and finance from the London School of Economics.